Integrated Health Pharmacology in Bariatric Surgery

Mon 8:00 AM -- 12:00 PM

Location: Room 31C

Track: CE

Course Directors:
Bridget Mattson, PharmD and Kristine Steffen, PharmD, PhD

*Up to 4 CE credits are available.*

Course Overview and Target Audience:
The pharmacology course involves a combined clinical practice and research-focused approach to discussing pharmacotherapy and pharmacokinetic considerations relevant to the bariatric surgery patient. The first part of the course is designed to provide an overview of pharmaceutical care for the bariatric surgery patient.  The role of the pharmacist in the overall management of patient care will be discussed, along with the process of conducting a drug evaluation for a bariatric surgery patient.  Pharmacotherapy considerations in the pre-operative, peri-operative, and post-operative time-periods will be addressed, as well as issues related to impaired or enhanced drug absorption, discussion of the potential mechanisms underlying these changes, vitamin and mineral supplementation and potential drug-vitamin interactions to avoid.  The second portion of the course will describe the limited research conducted in the area of bariatric surgery and pharmacokinetics, discuss research needs in this area, and present data recently collected on antidepressants and describe how these data may relate to psychiatric outcomes in bariatric surgery patients. This course is designed for Integrated Health members and physicians involved with the pharmaceutical care of bariatric patients, including pharmacists, nurses, all other allied health professionals and physicians.

Course Objectives:
Upon completion of the activity, with regards to the bariatric surgery patient, participants should be able to:

  • Describe the role of the pharmacist in each phase of care
  • Define potential mechanisms impacting drug absorption
  • Restate the process for conducting a drug evaluation
  • Discuss pharmaceutical considerations for vitamins/supplements
  • Explain study design and research needs
  • Summarize recent data on antidepressants and how it may relate to psychiatric outcomes

Course Outline:


Welcome and Introduction – Bridget Mattson, PharmD and Kristine Steffen, PharmD, PhD

The Role Pharmacist on the Bariatric Team: Pre-Op, Peri-Op and Post-Op  – April Smith, PharmD, BCPS; Jennifer Catella, PharmD, BCPS; Bridget Mattson, PharmD

Drug Absorption Issues/Mechanisms – April Smith, PharmD, BCPS

Conducting a Drug Evaluation for the Bariatric Patient – Bridget Mattson, PharmD

Pharmaceutical Considerations with Vitamins/Supplements – Jennifer Catella, PharmD, BCPS

Refreshment Break in the Expo Center

Study Design & Upcoming Research Needs for Bariatric Patients – Kristine Steffen, PharmD, PhD

Review of Data Collected for Neuropsychiatric Research Institute To Date & Clinical Implications of Data on Psychiatric Outcomes – James Mitchell, MD

Pharmacy Consult Services: Current Practices and Outcomes – April Smith, PharmD, BCPS; Jennifer Catella, PharmD, BCPS; Bridget Mattson, PharmD

Case Studies – All Faculty

Panel Q&A – All Faculty


// Content is tentative and subject to change //

Comments are closed.